Sumatriptan (Migratan (100 mg)) is a selective serotonin receptor agonist, prescribed for the acute treatment of migraine attacks with or without aura in adults (severe, throbbing headaches that ...

Sumatriptan (Suminat (100 mg)) is a selective serotonin receptor agonist, prescribed for the acute treatment of migraine attacks with or without aura in adults (severe, throbbing headaches that ...

Triptans are effective medicines used to treat migraine headaches. They significantly reduce pain within two hours for most people. Complete relief is less common, but the likelihood may be greater if ...

Drug maker Ranbaxy Laboratories said it has received final approval of the US health watchdog to manufacture and market in the country Sumatriptan Succinate Tablets used for the treatment of migraine ...

MUMBAI, Feb 1 (Reuters) - Drug maker Aurobindo Pharma Ltd said on Friday it received tentative approval from the U.S. Food and Drug Administration for its sumatriptan succinate tablets, used to treat ...

Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine --Migraine Sufferers ...

NORTH WALES, Pa. Teva Pharmaceuticals on Monday announced the availability of sumatriptan succinate tablets, which is bioequivalent to GlaxoSmithKline’s Imitrex tablets and indicated for the treatment ...

1 Pediatric Headache Fellow, Department of Pediatric Neurology, Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, 778 Long Ridge Rd, Stamford, CT 06902, USA. 2 ...

Ranbaxy announced that it has settled all matters relating to possible patent litigation with GlaxoSmithKline regarding Sumatriptan Succinate tablets, used for treating migraine. NEW DELHI: Ranbaxy ...

Subcutaneous sumatriptan 6 mg is undeniably an excellent treatment of migraine. However, some patients have avoided using 6 mg sumatriptan because of unpleasant or unwanted side effects. To evaluate ...